A one-year prospective study of the safety, tolerability and pharmacokinetics of the highest available dose of paliperidone palmitate in patients with schizophrenia

Authors
Category Primary study
JournalBMC Psychiatry
Year 2012
This article has no abstract
Epistemonikos ID: d27850e5049f92f22ce0ea27689994c4dd18eceb
First added on: Feb 06, 2025